Skip to main content

Abstract

In the past few decades a variety of disorders of amino acid and organic acid metabolism has been described with major implications for the developing nervous system. Organic acids include fatty acids, ketoacids, a number of other endogenous and exogenous acids, and, strictly speaking, also amino acids. However, in medicine, it is usual to separate amino acids from the other organic acids.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Agrawal HC, Bone AH, Davison AN (1969) Inhibition of brain protein synthesis by phenylalanine. Biochem J 112: 27

    Google Scholar 

  • Anderson JM (1969) Spongy degeneration in the white matter of the central nervous system in the newborn: pathological findings in three infants, one with hyperglycinaemia. J Neurol Neurosurg Psychiat 32: 328–337

    Article  PubMed  CAS  Google Scholar 

  • Chou SM, Waisman HA, Wis M (1965) Spongy degeneration of the central nervous system. Arch Path 79: 357–363

    PubMed  CAS  Google Scholar 

  • Corner BD, Holton JB, Norman RM, Williams PM, et al. (1968) A case of histidinemia controlled with a low histidine diet. Pediatrics 41: 1074–1081

    PubMed  CAS  Google Scholar 

  • Duchen LW, Jacobs JM (1984) Nutritional deficiencies and metabolic disorders. In: Hume Adams J, Corsellis JAN, Duchen LW, eds. Greenfield’s Neuropathology, 4th ed. London: Edward Arnold: 573–626

    Google Scholar 

  • Gerstl B, Malamud N, Eng LF, Hayman RB (1967) Lipid alterations in human brains in phenylketonuria. Neurology 17: 51–57

    Article  PubMed  CAS  Google Scholar 

  • Haagen AAM, Duran M (1987) Absence of increased succinylacetone in the urine of a child with hereditary tyrosinaemia type I. J Inher Metab Dis 10: 323–325

    Article  Google Scholar 

  • Kidouchi K, Sugiyama N, Morishita H, Kobayashi M, et al. (1987) Identification of glutarylcarnitine in glutaric acid-uria type I. J Inher Metab Dis 10: 279–281

    Article  Google Scholar 

  • Malamud N (1966) Neuropathology of phenylketonuria. J Neuropath Exp Neurol 25: 254–268

    Article  PubMed  CAS  Google Scholar 

  • Martin JK, Norman RM (1967) Maple syrup urine disease in an infant with microgyria. Develop Med Child Neurol 9: 152–159

    Article  PubMed  CAS  Google Scholar 

  • Menkes JH, Solcher H (1967) Maple syrup disease. Arch Neurol 16: 486–491

    Article  PubMed  CAS  Google Scholar 

  • Menkes JH (1967) The pathogenesis of mental retardation in phenylketonuria and other inborn errors of amino acid metabolism. Pediatrics 39: 297–308

    PubMed  CAS  Google Scholar 

  • Moser HW (1977) Brain amino acid metabolism. In: Vin-ken PJ, Bruyn GW, eds. Handbook of clinical neurology, vol 29. Amsterdam: North Holland Publishing Company: 17–28

    Google Scholar 

  • Pollitt RJ, Losty H, Westwood A (1987) 3-Hydroxydicarboxylic aciduria: A distinctive type of intermittent dicarboxylic aciduria of possible diagnostic significance. J Inher Metab Dis 10: 266–269

    Google Scholar 

  • Prensky AL, Moser HW (1966) Brain lipid, proteolipids, and free amino acids in maple syrup urine disease. J Neurochem 13: 863–874

    Article  PubMed  CAS  Google Scholar 

  • Silberberg DH (1967) Phenylketonuria metabolites in cerebellum culture morphology. Arch Neurol 17: 524–529

    Article  PubMed  CAS  Google Scholar 

  • Silberberg DH (1969) Maple syrup urine disease metabolites studied in cerebellum cultures. J Neurochem 16: P 1141–1146

    Article  PubMed  CAS  Google Scholar 

  • Swaiman KF, Menkes JH, DeVivo DL, Prensky AL (1982) Metabolic disorders of the central nervous system. In: Swaiman and Wright, The practice of pediatric neurology, vol 1. St. Louis: The CV Mosby Company: 472–600

    Google Scholar 

  • Vamecq J, Hoffmann de E, Van Hoof F (1985) Mitochondrial and peroxisomal metabolism of glutaryl-CoA. Eur J Biochem 146: 663–669

    Article  PubMed  CAS  Google Scholar 

  • Vamecq J, Hoof Van F (1984) Implication of a peroxisomal enzyme in the catabolism of glutaryl-CoA. Biochem J 221: 203–211

    PubMed  CAS  Google Scholar 

  • Visser de M, Scholte HR, Schutgens RBH, Bolhuis PA, et al. (1986) Riboflavin-responsive lipid-storage myopathy and glutaric aciduria type II of early adult onset. Neurology 36: 367–372

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Valk, J., van der Knaap, M.S. (1989). Disorders of Amino Acid and of Organic Acid Metabolism. In: Magnetic Resonance of Myelin, Myelination, and Myelin Disorders. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-02568-0_26

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-02568-0_26

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-02570-3

  • Online ISBN: 978-3-662-02568-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics